We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

115 hedge funds and large institutions have $358M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 28

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

14% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $2.47M

1% more funds holding

Funds holding: 114 → 115 (+1)

34% less capital invested

Capital invested by funds: $541M → $358M (-$184M)

Holders
115
Holders Change
+1
Holders Change %
+0.88%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
41
Reduced
28
Closed
13
Calls
$2.8M
Puts
$2.47M
Net Calls
+$334K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$26.3M
2
Fisher Asset Management
Fisher Asset Management
Washington
+$13.4M
3
JP Morgan Chase
JP Morgan Chase
New York
+$5.92M
4
Goldman Sachs
Goldman Sachs
New York
+$3.98M
5
Nordea Investment Management
Nordea Investment Management
Sweden
+$3.38M

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$8.82M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.77M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$7.83M
4
Morgan Stanley
Morgan Stanley
New York
-$3.68M
5
N
Nuveen
North Carolina
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
101
Sonora Investment Management
Arizona
$17K – – –
Simplex Trading
102
Simplex Trading
Illinois
$17K +$847 +52 +7%
AF
103
Allworth Financial
California
$17K +$20.6K +1,262 New
US Bancorp
104
US Bancorp
Minnesota
$16K – – –
CAPTRUST Financial Advisors
105
CAPTRUST Financial Advisors
North Carolina
$13K -$32.6K -2,000 -67%
PCM
106
Penserra Capital Management
California
$12K +$81 +5 +0.5%
Macquarie Group
107
Macquarie Group
Australia
$11K – – –
CFGS
108
Concourse Financial Group Securities
Alabama
$7K – – –
Daiwa Securities Group
109
Daiwa Securities Group
Japan
$2K +$1.19K +73 +101%
DFCM
110
Dark Forest Capital Management
Puerto Rico
$1K -$10K -616 -92%
FCA
111
FinTrust Capital Advisors
South Carolina
$1K – – –
GRP
112
Global Retirement Partners
California
$1K – – –
CFFP
113
Center for Financial Planning
Michigan
$1K +$1.65K +101 New
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
$18 – – –
Point72 Asset Management
115
Point72 Asset Management
Connecticut
– -$8.77M -399,844 Closed
PP
116
PDT Partners
New York
– -$1.12M -51,094 Closed
BCM
117
Burrage Capital Management
Massachusetts
– -$1.05M -47,708 Closed
JF
118
Jump Financial
Illinois
– -$744K -33,902 Closed
Jacobs Levy Equity Management
119
Jacobs Levy Equity Management
New Jersey
– -$241K -10,989 Closed
VFA
120
Valeo Financial Advisors
Indiana
– -$234K -10,646 Closed
Principal Financial Group
121
Principal Financial Group
Iowa
– -$213K -9,687 Closed
1C
122
1623 Capital
Virginia
– -$207K -9,432 Closed
Squarepoint
123
Squarepoint
New York
– -$205K -9,332 Closed
FC
124
FORA Capital
Florida
– -$45K -2,045 Closed
BCV
125
Banque Cantonale Vaudoise
Switzerland
– -$33K -1,500 Closed
2 3 4
5
6

GTHX Hedge Fund Activity: Q3 2021 in Review

115 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q3 2021, worth a combined $358M — down 34% from $541M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GTHX positions and 13 closed out — a net gain of 2 holders — while 41 added to existing stakes and 28 trimmed.

The largest buyer was State Street, adding an estimated $26.3M. The largest seller was Two Sigma Investments, cutting an estimated $8.82M.

  • 115 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q3 2021, up from 114 in Q2 2021.
  • Funds reported $358M of G1 Therapeutics, Inc. Common Stock stock for Q3 2021, down 34% quarter-over-quarter.
  • 15 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q3 2021 and 13 closed out, a net change of +2 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q3 2021 was State Street, an estimated $26.3M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q3 2021 was Two Sigma Investments, an estimated $8.82M sold.

Based on aggregated 13F filings for Q3 2021.